首页> 外文OA文献 >A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup

【2h】

A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup

机译：使用非机器人线性加速器和实时目标跟踪的saBR（立体定向烧蚀身体放射治疗）用于低风险前列腺癌的II期试验：毒性，生活质量和疾病控制结果的报告，最少5年的随访

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Constantine Anastasios Mantz;
展开▼
作者单位

展开▼
年度 2014
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Definitive External Beam Radiation Therapy with Stereotactic Body Radiation Therapy Boost for FIGO Stage IB - IIB Cancer of the Cervix: Minimum 5-Year Disease Control, Toxicity, and Quality of Life Outcomes From a Phase 2 Trial [J] . Mantz C. A. International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：确定外部光束放射治疗型椎体定向体辐射疗法促进Figo Stage IB - IIB癌症癌症：最低5年疾病控制，毒性和生命质量从第2期试验
2. Definitive External Beam Radiation Therapy with Stereotactic Body Radiation Therapy Boost for FIGO Stage IB - IIB Cancer of the Cervix: Minimum 5-Year Disease Control, Toxicity and Quality of Life Outcomes From a Phase 2 Trial [J] . Mantz C. A. International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：确定外部光束放射治疗具有刻膜体放射治疗的Figo Stage IB - IIB癌症：最低5年疾病控制，毒性和生活质量结果来自相2试验
3. Definitive External Beam Radiation Therapy With Stereotactic Body Radiation Therapy Boost for FIGO Stage IB-IIB Cancer of the Cervix: Minimum 4-Year Disease Control, Toxicity, and Quality of Life Outcomes from a Phase 2 Trial [J] . Mantz C. A. International Journal of Radiation Oncology, Biology, Physics . 2017,第2Suppla期

机译：确定外部光束放射治疗具有定向型身体放射治疗的椎间飞机阶段IB-IIB癌症癌：最低4年疾病控制，毒性，以及生命质量和生活质量结果从2期试验
4. A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity Quality of Life and Disease Control Outcomes with 5-Year Minimum Follow-Up [O] . Constantine Mantz 2014

机译：使用非机器人直线加速器和实时目标跟踪对低风险前列腺癌进行立体定向消融身体放疗的II期试验：毒性生活质量和疾病控制结果的报告（最少5年）
5. A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Follow-Up [O] . Constantine Mantz 2014

机译：使用非机器人线性加速器和实时目标跟踪进行立体定向消融身体放射治疗低风险前列腺癌的II期试验：毒性，生活质量和疾病控制结果的报告，5年最低随访

A Phase II Trial of SABR (Stereotactic Ablative Body Radiotherapy) for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life and Disease Control Outcomes with 5-Year Minimum Followup

著录项

引文网络

相似文献

相关主题

期刊订阅